fluconazole has been researched along with Lung Neoplasms in 13 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of fluconazole as an alternative treatment for controlling hypercortisolism in Cushing's syndrome and to determine its effect on glucocorticoid production in vitro." | 3.73 | Long term control of hypercortisolism with fluconazole: case report and in vitro studies. ( Luger, A; Maier, C; Nowotny, P; Riedl, M; Schima, W; Zettinig, G, 2006) |
| "Pulmonary Cryptococcosis is a common fungal infection mainly caused by Cryptococcus neoformans/C." | 2.66 | Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review. ( Fang, J; Han, Y; Hu, H; Qiu, X; Wang, L; Xia, R; Yao, K; Zhang, W, 2020) |
| " To predict the potential influence of different triazoles (voriconazole, fluconazole, and itraconazole) on the pharmacokinetics of crizotinib by modeling and simulation the physiologically based pharmacokinetic models were established and validated in virtual cancer subjects through Simcyp software based on the essential physicochemical properties and pharmacokinetic data collected." | 1.72 | Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib. ( Chen, L; Chen, W; Li, L, 2022) |
| "The relationship between pulmonary Cryptococcus infection and breast cancer is also discussed." | 1.36 | Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. ( Cheng, YL; Hsu, GC; Hsu, HM; Hsu, KF; Ou, KW; Yu, JC, 2010) |
| "HSA levels in cancer patients were significantly decreased (p < 0." | 1.29 | Protein binding of itraconazole and fluconazole in patients with cancer. ( Arredondo, G; Calvo, R; Marcos, F; Martínez-Jordá, R; Suarez, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 1 |
| Li, L | 1 |
| Chen, W | 1 |
| Fu, Y | 1 |
| Li, Y | 1 |
| Ma, Y | 1 |
| He, X | 1 |
| Xun, X | 1 |
| Cui, Y | 1 |
| Fan, L | 1 |
| Dong, Z | 1 |
| Zhang, Y | 1 |
| Zhang, SX | 1 |
| Trivedi, J | 1 |
| Toll, AD | 1 |
| Brahmer, J | 1 |
| Hales, R | 1 |
| Bonerigo, S | 1 |
| Zeng, M | 1 |
| Li, H | 1 |
| Yung, RC | 1 |
| Yao, K | 1 |
| Qiu, X | 1 |
| Hu, H | 1 |
| Han, Y | 1 |
| Zhang, W | 1 |
| Xia, R | 1 |
| Wang, L | 1 |
| Fang, J | 1 |
| Johnson, K | 1 |
| Dhamrah, U | 1 |
| Amin, A | 1 |
| Masci, J | 1 |
| Lourdes, LS | 1 |
| Mitchell, CL | 1 |
| Glavin, FL | 1 |
| Schain, DC | 1 |
| Kaye, FJ | 1 |
| How, SH | 1 |
| Kuan, YC | 1 |
| Ng, TH | 1 |
| Ramachandram, K | 1 |
| Fauzi, AR | 1 |
| Ou, KW | 1 |
| Hsu, KF | 1 |
| Cheng, YL | 1 |
| Hsu, GC | 1 |
| Hsu, HM | 1 |
| Yu, JC | 1 |
| Pan, AH | 1 |
| Janner, D | 1 |
| Huang, CJ | 1 |
| Yang, MC | 1 |
| Ueng, SH | 1 |
| Riedl, M | 1 |
| Maier, C | 1 |
| Zettinig, G | 1 |
| Nowotny, P | 1 |
| Schima, W | 1 |
| Luger, A | 1 |
| Arredondo, G | 1 |
| Calvo, R | 1 |
| Marcos, F | 1 |
| Martínez-Jordá, R | 1 |
| Suarez, E | 1 |
| Hirasaki, S | 1 |
| Ijichi, T | 1 |
| Fujita, N | 1 |
| Araki, S | 1 |
| Gotoh, H | 1 |
| Nakagawa, M | 1 |
2 reviews available for fluconazole and Lung Neoplasms
| Article | Year |
|---|---|
Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature.
Topics: Administration, Oral; Aged; Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Cryptococcosis; Crypt | 2019 |
Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review.
Topics: Aged; Comorbidity; Cryptococcosis; Fluconazole; Humans; Immunocompetence; Lung Diseases, Fungal; Lun | 2020 |
11 other studies available for fluconazole and Lung Neoplasms
| Article | Year |
|---|---|
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lu | 2022 |
Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC-MS/MS.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Chromatography, Liqui | 2023 |
Case Report: A Great Mimicker of Neoplasm: Pulmonary Cryptococcosis in an Immunocompetent Host After High-Altitude Descent.
Topics: Aged, 80 and over; Altitude; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, | 2021 |
Recurrent dermatophytosis (Majocchi granuloma) associated with chemotherapy-induced neutropenia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Flucon | 2014 |
An unusual cause of haemoptysis and headache: cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Fluconazole; Head | 2008 |
Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection.
Topics: Antifungal Agents; Antigens, Fungal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cryptococcosis; Cr | 2010 |
Lung mass in a sixteen-year-old young man.
Topics: Adolescent; Antigens, Fungal; Biopsy, Needle; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Di | 2003 |
Large cryptococcoma mimicking lung cancer in an HIV-negative, type 2 diabetic patient.
Topics: Aged; Antifungal Agents; Biopsy, Needle; Cryptococcosis; Diabetes Mellitus, Type 2; Diagnosis, Diffe | 2005 |
Long term control of hypercortisolism with fluconazole: case report and in vitro studies.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged, 80 and over; Antifungal Agents; Cell Line, Tu | 2006 |
Protein binding of itraconazole and fluconazole in patients with cancer.
Topics: Adult; Aged; Antifungal Agents; Blood Proteins; Breast Neoplasms; Colonic Neoplasms; Esophageal Neop | 1995 |
Fungemia caused by Hansenula anomala: successful treatment with fluconazole.
Topics: Carcinoma, Small Cell; Female; Fluconazole; Fungemia; Humans; Lung Neoplasms; Middle Aged; Opportuni | 1992 |